Department of Clinical Pharmacy and Translational Science
Mission
We educate, discover, and serve Tennesseans and our nation.
Vision
To be the leading clinical pharmacy and translational science department in the nation through outstanding education, discovery, and service.
In pursuing the mission of the Department of Clinical Pharmacy and Translational Science, the faculty and staff are guided by these shared values, which are the foundation of its practices, spirit, and culture:
Core Values
- Dedication to the pursuit of excellence in education and clinical care.
- Dedication to the profession of pharmacy.
- Dedication to our students and alumni.
- Dedication to the community.
- Active engagement in the profession, public service, and outreach.
- Competitiveness in research.
- Professionalism.
- Mutual trust and respect.
- Intellectual honesty and academic integrity.
- Mutual responsibility and accountability.
- Collaboration and teamwork.
- Continuous quality improvement.
- An orientation to the future.
- Development of leaders.
Leadership
Chair and Professor
听
Professor and Vice Chair for Research
听
Professor and Vice Chair for Education
First Tennessee Chair of Excellence
Brian Peters, PhD
First Tennessee Chair of Excellence & Professor, Department of Clinical Pharmacy & Translational Science
Brian M Peters, PhD is the First Tennessee Endowed Chair of Excellence in Clinical Pharmacy and Professor at the University of Tennessee Health Science Center College of Pharmacy, with a joint appointment in the Department of Microbiology, Immunology, and Biochemistry College of Medicine. He holds a BS in Microbiology from Penn State, a PhD from the University of Maryland鈥擝altimore, and completed postdoctoral work at the LSU Health Science Center. Joining UTHSC in 2015, he teaches microbiology and immunology courses, has over 100 peer-reviewed publications, and has been invited to speak at numerous national and international conferences. Additionally, he has mentored over 40 trainees and serves on various scientific journal editorial boards and NIH review panels. His research, supported by over $7 million in NIH funding to date since 2015, focuses on fungal-host molecular mechanisms, including vulvovaginal candidiasis and polymicrobial invasive disease, and involves collaborations on improving fungal infection outcomes in both adult and pediatric populations.
